Rockefeller Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.76M | Sell |
14,080
-392
| -3% | -$106K | 0.01% | 1037 |
|
|
2025
Q4 | $3.63M | Sell |
14,472
-1,916
| -12% | -$509K | 0.01% | 992 |
|
|
2025
Q3 | $4.7M | Buy |
16,388
+3,040
| +23% | +$814K | 0.01% | 843 |
|
|
2025
Q2 | $3.5M | Buy |
13,348
+895
| +7% | +$218K | 0.01% | 907 |
|
|
2025
Q1 | $2.9M | Sell |
12,453
-191
| -2% | -$46.4K | 0.01% | 903 |
|
|
2024
Q4 | $2.9M | Sell |
12,644
-793
| -6% | -$182K | 0.01% | 881 |
|
|
2024
Q3 | $3M | Sell |
13,437
-7,306
| -35% | -$1.61M | 0.01% | 857 |
|
|
2024
Q2 | $4.22M | Sell |
20,743
-703
| -3% | -$143K | 0.01% | 743 |
|
|
2024
Q1 | $4.69M | Buy |
21,446
+2,154
| +11% | +$474K | 0.01% | 711 |
|
|
2023
Q4 | $4.39M | Buy |
19,292
+1,006
| +6% | +$211K | 0.01% | 672 |
|
|
2023
Q3 | $3.68M | Sell |
18,286
-3,525
| -16% | -$744K | 0.01% | 653 |
|
|
2023
Q2 | $3.84M | Buy |
21,811
+2,364
| +12% | +$459K | 0.01% | 658 |
|
|
2023
Q1 | $3.83M | Buy |
19,447
+1,908
| +11% | +$393K | 0.02% | 633 |
|
|
2022
Q4 | $3.55M | Sell |
17,539
-596
| -3% | -$116K | 0.02% | 594 |
|
|
2022
Q3 | $3.19M | Buy |
18,135
+4,876
| +37% | +$998K | 0.02% | 630 |
|
|
2022
Q2 | $2.67M | Buy |
13,259
+2,570
| +24% | +$548K | 0.01% | 677 |
|
|
2022
Q1 | $2.42M | Sell |
10,689
-6,623
| -38% | -$1.56M | 0.01% | 744 |
|
|
2021
Q4 | $4.67M | Buy |
17,312
+3,022
| +21% | +$748K | 0.02% | 561 |
|
|
2021
Q3 | $3.45M | Buy |
14,290
+3,722
| +35% | +$938K | 0.02% | 593 |
|
|
2021
Q2 | $2.5M | Sell |
10,568
-109
| -1% | -$24.8K | 0.01% | 655 |
|
|
2021
Q1 | $2.34M | Buy |
10,677
+147
| +1% | +$29.5K | 0.02% | 545 |
|
|
2020
Q4 | $1.84M | Buy |
10,530
+3,673
| +54% | +$634K | 0.01% | 540 |
|
|
2020
Q3 | $1.11M | Buy |
6,857
+4,829
| +238% | +$765K | 0.01% | 575 |
|
|
2020
Q2 | $289K | Buy |
2,028
+1,271
| +168% | +$176K | ﹤0.01% | 857 |
|
|
2020
Q1 | $82K | Buy |
757
+479
| +172% | +$69K | ﹤0.01% | 1076 |
|
|
2019
Q4 | $40K | Buy |
278
+57
| +26% | +$8.23K | ﹤0.01% | 1203 |
|
|
2019
Q3 | $32K | Buy |
221
+60
| +37% | +$8.76K | ﹤0.01% | 1097 |
|
|
2019
Q2 | $24K | Sell |
161
-449
| -74% | -$62.6K | ﹤0.01% | 978 |
|
|
2019
Q1 | $80K | Buy |
610
+454
| +291% | +$55.9K | ﹤0.01% | 808 |
|
|
2018
Q4 | $17K | Hold |
156
| – | – | ﹤0.01% | 636 |
|
|
2018
Q3 | $23K | Hold |
156
| – | – | ﹤0.01% | 500 |
|
|
2018
Q2 | $24K | Hold |
156
| – | – | ﹤0.01% | 512 |
|
|
2018
Q1 | $22K | Buy |
+156
| New | +$22.9K | ﹤0.01% | 469 |
|
Other funds holding LH
VCM
VPM
Rockefeller Capital Management's LH Position: Q1 2026 in Review
Rockefeller Capital Management reduced its Labcorp (LH) stake by 2.7% in Q1 2026, selling an estimated $106K and leaving 14,080 shares worth $3.76M. The position accounts for 0.01% of the portfolio, ranked #1037.
Rockefeller Capital Management first reported a position in LH in Q1 2018 and has held it in 33 quarters since. The position peaked at $4.7M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Rockefeller Capital Management held 14,080 shares of Labcorp worth $3.76M as of Q1 2026.
- Rockefeller Capital Management sold 392 Labcorp shares in Q1 2026, an estimated $106K.
- Labcorp made up 0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1037 holding.
- Rockefeller Capital Management first reported a position in Labcorp in Q1 2018 and has held it in 33 quarters since.
- Rockefeller Capital Management's Labcorp position peaked at $4.7M in Q3 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.